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INTRODUCTION 
 
 Eclampsia is the term coined by Hippocrates in 4th century BC . This greek 
term eclampsia means sudden development. Preeclampsia is a night mare to 
obstetrician and also obstetric anesthesiologist because of the danger it imposes 
both to mother and fetus. Selection of spinal anesthesia for severely 
preeclamptics patients requiring cesarean section is controversial. In 1985 
William in his text book of obstetrics recommended avoiding regional anesthesia 
because of the fear of sudden, severe hypotension induced by splanchnic 
blockade, immediate danger from pressor agents and subsequent danger from 
large volume of fluid given to correct hypotension. In early 1990’s several well 
conducted studies contradicted this doctrine . With the recent availability of 
PCWP monitoring and Thromboelastography, Regional anesthesia again came to 
play and it was accepted by many obstetric anesthesiologists. These studies 
made us to implement spinal anesthesia in preeclamptic patients and results of 
the study were discussed in detail in this dissertation. 
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AIM OF THE STUDY 
 
Our aim is to understand the following physiological variants in 
preeclamptic patients  in comparison to normal pregnant patients coming for 
cesarean section under Subarachnoid blockade like  
1. Hemodynamic variables 
2. Vasopressor requirement 
3. Total intravenous fluid requirement 
4. Vasopressor requirement 
5. Neonatal out come 
6. Postoperative hemodynamic stability  
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HISTORY OF OBSTETRIC ANAESTHESIA 
The position of woman in any civilization is an index of the advancement of 
that civilization.The position of woman is gauged best by the care given to her at 
the birth of her child. JAMES YOUNG SIMPSON – JANUARY 1847 used Diethyl 
ether to anesthetise a woman with a deformed pelvis for delivery. Simpsons most 
articulate and persuasive critic was CHARLES . D . MEIGS PROFESSOR OF 
MIDWIFERY at Jeffersson medical college . He questioned the safety of 
anesthesia on fetus and believed that any drug that abolishes pain will alter 
uterine contraction. JOHN SNOW anesthetized the Queen for her eighth delivery. 
This changed the reaction of public towards etherisation for child birth. 
Next major innovation in obstetric anesthesia came approximately 50 
years later. DAMMERSCHALFF - which means twilight sleep was a technique 
developed by VONSTEINBUCHEL and popularized by GAUSS of Freiberg . It 
combined opioids with scopolamine to make women amnestic and somewhat 
comfortable during labour. In 1853 - hollow metal needle and syringe was 
developed .This technical advance simplified administration of opioids and 
facilitated the development of twilight sleep. 
THE EFFECTS OF ANESTHESIA ON THE NEW BORN 
The idea that gases crosses placenta appeared long before the discovery 
of oxygen and carbondioxide. JOHN SNOW observed depressed neonatal 
breathing and motor activity and smelled ether on the breath of neonates 
delivered from mothers who had been given ether. 
IN 1953 – APGAR described a simple reliable system for evaluating 
newborns and showed that it was sufficiently sensitive to detect differences 
among neonates whose mothers had been anesthetized for cesarean section by 
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different techniques. Infants of woman  with spinal anesthesia had higher scores 
compared to general anesthesia. 
THE EFFECTS OF ANAESTHESIA ON LABOUR 
MEIGS said that Etherisation suppressed uterine function. 
JOHN SNOW withheld anaesthesia until the  second stage of labour and limited 
administration of drugs to brief periods during contraction. 
Regional anesthesia appeared during the first decades of twentieth 
century. The first papers describing obstetric applications of spinal ,lumbar, 
epidural, caudal, paravertebral, parasacral, pudendal nerve block appeared 
between 1900 and 1930. Recognition of the potential effects of Regiona 
anesthesia on labour developed more slowly and primarily  because obstetrician 
seldom uses it. Chief advantage of regional anesthesia – the relative absence of 
drug effect on infant was not recognized by obstetricians. CLELAND described 
his experience with paravertebral anesthesia , but he also wrote athoughtful 
analysis of nerve pathways mediating labour pain. Continuous caudal anesthesia 
introduced  by HINGSON AND EDWARDS in which a malleable needle remained 
in the sacral canal throughout labour. Small flexible plastic catheters eventually 
replaced malleable needles and made continuous epidural anesthesia even more 
popular. 
Ironically natural childbirth appeared just as regional anesthesia started to 
become popular and clinicians began to understand how to use it without 
disrupting labour progression. 
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CLASSIFICATION OF PREECLAMPSIA 
Working group of National high blood pressure education programme 
classified hypertension occurring during pregnancy as follows18 
1. Gestational Hypertension. (Formerly pregnancy induced hypertension or 
transient hyperstension) 
2. Preeclampsia. 
3. Eclampsia. 
4. Preeclampsia superimposed on chronic hypertension. 
5. Chronic hypertension. 
1) GESTATIONAL HYPERTENSION :-   
It is defined as systolic BP of greater than 140 mmHg and diastolic BP 
greater than 90 mmHg for the first time during pregnancy without  Proteinuria. 
The increase in BP return to normal within 12 weeks postpartum. So the final 
diagnosis is made only in the  postpartum period. Patient may have other signs of 
preeclampsia for example epigastric discomfort or thrombocytopenia. 
2) PREECLAMPSIA 
The term preeclampsia describes the development of hypertension with 
proteinuria after 20 weeks gestation. It is classified into two types. 
1) Mild preeclampsia 
2) Severe preeclampsia 
MILD PREECLAMPSIA : 
It is defined as BP of greater than 140/90 mmHg after 20 weeks gestation 
with proteinuria greater than 300mmHg /24 hours. 
SEVERE PREECLAMPSIA 
It is defined as BP greater than 160 mmHg systolic or greater than 110 
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mmHg diastolic on two occasions atleast 6 hours apart  while the patient is on 
bed rest  with any of the following  features of severity . 
FEATURES OF SEVERE PREECLAMPSIA: 
1. Serum creatinine > 1.2mg/dl 
2. Platelets < 100000/mm3 
3. Microangiopathic hemolysis 
4. Elevated ALT/AST 
5. Persistent headache 
6. Persistent epigastric  pain 
INDICATIONS OF SEVERITY:- 
Abnormality Mild Severe 
Diastolic B.P 
Proteinuria 
Headache 
Visual disturbances 
Upper abdominal pain 
Oliguria 
Convulsion 
Laboratory results: 
Serum Creatinine 
Thrombocytopenia 
Elevation of Liver 
enzymes 
Fetal growth restriction 
Pulmonary edema 
< 100 mmHg 
Trace to 1+ 
Absent 
Absent 
Absent 
Absent 
Absent 
  
Normal 
Absent 
Minimal 
Absent 
Absent 
Absent 
110 mmHg or higher 
Persistent 2+ or more 
Present 
Present 
Present 
Present 
       Present(eclampsia) 
          
Elevated 
Present 
Marked 
Obvious 
Present 
Present 
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3) ECLAMPSIA: 
 Eclampsia is occurrence of seizures in a woman with preeclampsia that 
cannot be attributed to other causes. Seizures are grand mal type which  may 
appear before, during or after labour.  
4) PREECLAMPSIA SUPERIMPOSED UPON CHRONIC HYPERTENSION:-  
It is defined as new onset proteinuria ≥ 300 mg / 24 hours in hypertensive 
women but no proteinuria before 20 weeks gestation or a sudden increase in 
proteinuria or blood pressure or platelet count < 100,000 / mm3 in women with 
hypertension and proteinuria before 20 weeks gestation. 
5) CHRONIC HYPERTENSION : 
The diagnosis of chronic underlying hypertension is suggested by. 
1) Hypertension (140/90mmhg or greater) antecedent to pregnancy. 
2) Hypertension (140/90mmhg or greater) detected before 20 weeks (unless 
there is gestational trophoblastic disease). 
3) Persistent hypertension long after delivery. 
Additional factors supporting diagnosis:- 
a) Multiparity and hypertension complicating pervious pregnancy other than 
the first. 
b) Strong family history of essential hypertension. 
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UNDER LYING CHRONIC HYPERTENSIVE DISORDERS: 
1) Essential familial hypertension. 
2) Arterial abnormalities. 
a) Renovascular hypertension 
b) Coarctation of aorta. 
3) Endocrine disorders. 
a) Diabetes 
b) Cushing’s Syndrome 
c) Primary Aldosteronism 
d) Pheochromocytoma 
e) Thyrotoxicosis. 
4) Glomerulo nephritis 
5) Reno prival hypertension. 
a) Chronic glomerulonephritis 
b) Chronic renal insufficiency 
c) Diabetic nephropathy 
6) Connective tissue diseases : 
     a) Systemic lupus erythematosus   
           b) Scleroderma 
           c ) Polyarteritis nodosa. 
     7)  Polycystic kidney disease 
     8)  Acute renal failure 
     9)  Obesity. 
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EPIDEMIOLOGY 
 It is the third highest cause of direct maternal death. Incidence varies 
among different countries or populations . It is 5% according to (Williams 
Obstetrics) 22nd edition and  8 – 10% (Mudaliar menon) Tenth edition. 
RISK FACTORS 
Risk factors for preeclampsia is given under the following headings. 
I. Partner related 
1. Nulliparous / primi / teenage 
2. Limited sperm exposure / donar inseminisation / oocyte donation 
3. Oral sex (risk reduction) 
4. Partner who fathered 
              Preeclamptic pregnancy in another women. 
II. Non partner related 
1. H/O previous preeclampsia  
2. Age,interval between pregnancy 
III. Presence of specific underlying disorder 
1. Chronic HT , Renal disease 
2. Obesity,   Insulin  resistance,   low birth weight,   gestational diabetes 
milletus,  Type I   Diabetes milletus,                           
3. Activated   protein - C  resistance,  protein – S deficiency. 
     4.  Anti phospholipid antibodies  
      5.  Hyper homocystenimia : sickle cell disease  
IV. Exogenous  
1. Smoking  
2. Environmental factors – high altitude  
3. In utero diethyl stilbestrol exposure. 
4. Poor socioeconomic status .  
10 
 
PATHOPHYSIOLOGY 
Preeclampsia is a multisystem disorder that primarily affects the maternal 
cardiovascular , central nervous system and genitor urinary system. However all 
systems may be involved to some degree.21 
I. CARDIOVASCULAR CHANGES:- 
a) In Gestational Hypertension there is increase in Cardiac output and decrease  
in peripheral vascular resistance.  
b) In preeclampsia the Cardio Vascular changes  were classified by Cotton et al  
as follows. 
1. Increased   Cardiac  output,  Normal  or  increased  systemic  vascular 
resistance, Normal or slightly decreased blood volume and filling 
pressures. 
2. Normal    Cardiac    output,    increased    systemic   vascular resistance, 
decreased filling pressure. 
3. Increased   systemic   vascular   resistance,   decreased  blood volume, 
decreased Left ventricular function.  
Three factors may explain these differences 
         1) Women with preeclampsia might present with a spectrum of  
    cardiovascular   findings  dependant  upon  both  severity  &  
    duration. 
2) Chronic    underlying    disease    may    modify   the   clinical 
    presentation.  
3) Therapeutic interventions may alter these findings. 
Three Separate groups based on Clinical Management  
1) No therapy for preeclampsia. 
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2) Magnesium sulfate and Hydralazine without large volumes of 
intravenous fluid.    
3) Magnesium sulfate and Hydralazine plus intravenous volume loading.  
COLLOIDAL ONCOTIC PRESSURE: 
Colloidal oncotic pressure is already decreased in normal pregnancy  
because of hypoalbuminemia , often is further decreased in preeclamptic women. 
This promotes increased risk for pulmonary edema .  
COLLOIDAL ONCOTIC PRESSURE IN VARIOUS STAGES OF PREGNANCY 
 Antepartum Postpartum 
Normal pregnancy 22mmHg 17 mmHg 
Preeclampsia 18mmHg 12mmHg 
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SEVERE PREECLAMPSIA AND ECLAMPSIA:- 
ASSOCIATED HEMODYNAMIC MEASUREMENTS:- 
This is a study showing comparison of various hemodynamic variables  
before starting therapy and after initiating therapy by various authours. 23 
Therapy No C.O (L/min) 
PCWP 
(mmhg)
Left 
Ventricular 
Stroke work 
index 
(g.m.m2) 
Systemic 
vas. 
Resistance 
(dyne / sec) 
Per cm-5 
 
1. Before Therapy 
 
   
 
 
 
 
 
 
    a.Groenendijk etal.(1984) 10 4.66 3.3 44 1943 
 
    b.Visser&wallenbeg 
          (1995) 
 
87 
 
(3.3)6 
 
7 
 
NA 
 
3003 
        With therapy 
2. Magnesium, Hydralazine 
    fluid restriction  
 
 
 
 
    
   a. Benedicts etal (1980) 10 7.4 6.0 82 1322 
    
   b. Hankins etal (1984)  
 
8 6.7 3.9 66 1357 
3.Magnesium, Hydralazine 
   volume expansion. 
 
  
 
 
 
 
 
 
 
  a. Rafferty with Berkowitz 
     (1980) 
 
3 
 
11.0 7.0 89 780 
  
 b. Phelan and yurth (1982) 
 
10 9.3 16.0 89 1042 
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BLOOD VOLUME  CHANGES 
Pouta et al demonstrated that an intravenous fluid bolus resulted in a 
greater increase in CVP in preeclamptic women than in normotensives.19 
 
Tabular column showing the blood volume changes 
Variables Eclampsia Non pregnant Normal pregnant 
1)Blood Volume (m1) 
 
2)Change (%) 
 
3)Hematocrit 
 
3530 
 
+16 
 
40.5 
3035 
 
 
 
38.2 
4425 
 
(+47) 
 
34.7 
 
   * Hemo concentration is a hallmark of eclampsia. 
   * Woman with eclampsia therefore is unduly sensitive to vigorous fluid 
therapy administered in an attempt to expand the contracted blood volume 
to normal pregnancy levels. She is sensitive as well to even normal blood 
loss at delivery. 
HEMATOLOGICAL CHANGES:- 
Well documented coagulation abnormalities occur in patients with 
preeclampsia. 
They are as follows 
   *  Thrombocytopenia. 
   *  Reduction in clotting factors 
   *  Erythrocytes are traumatised and bizarreshaped. They undergo rapid 
hemolysis because of altered red cell membrane 
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Coagulation disturbances leading to hypercoagulability is listed below 
    *  Fibrin degradation products increased 
    *  Plasma fibrinogen – decreased 
    *  Fibirnogen decreased  
   *  Fibrinopeptide A increased 
   *  Anti thrombin III decreased 
    *  Factor IX, X, XI, XII decreased 
    *  Fibrin monomer – positive 
    *  Thrombin time – prolonged. 
THROMBOCYTOPENIA:- 
Burrows et al found elevated platelet associated immunoglobulin G in 35% 
of preeclamptic patients which suggest that an immune mechanism is probably 
responsible for the thrombocytopenia Platelets demonstrate a 50% reduction in 
sensitivity to PGI2  
CAUSES:-  
 * Despite of increased platelet production, platelet activation and platelet      
consumption process is increased.                
*  Thrombopoietin  level  is increased  - a cytokine that promotes megakaryocytes 
proliferation.  
Evidence of platelet activation include 
1) Increased release of beta – thromboglobulin by platelets 
2) Appearanceof megathrombocytes (giant platelets) in peripheral blood 
3)  Count < 100 000 ml – severe disease. 
 After delivery platelet count increased progressively to reach a normal 
level in 3 days. 
15 
 
ERYTHROCYTE:- 
Red blood cell undergoes the following changes 
   *  Hemolysis  
   *  Schistocytosis, spherocytosis, reticulocytosis     
   *  Hemoglobinuria & occasionally hemoglobinemia -   Changes due to 
increased erythrocyte membrane fluidity. 
OTHER CLOTTING FACTORS:- 
   * Antithrombin III –decreased 
   * Fibronectin – a glycoprotein associated with vascular endothelial cell 
basements membrane is elevated in women with preeclampsia.  
ENDOCRINE AND METABOLIC CHANGES:- 
Renin angiotensin aldosterone system (RAAS) undergoes complex 
pathological changes which is tabulated below.32 
ENDOCRINE CHANGES:- 
 This tabular column depicts the changes in Renin Angiotensin 
Aldosterone system. 
 Normal Pregnancy    Preeclampsia 
Renin 
Increased 
 
Decreased 
 
Angiotensin II 
 
Increased 
 
 
Decreased 
 
Aldosterone 
 
Increased 
 
Decreased 
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PREECLAMPSIA:- 
  
Sodium retention / Hypertension 
 
↓ 
 
Renin secretion by Juxta glomemrular cells decreases 
 
↓ 
 
Angiotensinogen →  Angiotensin I  → Angiotensin II 
(decreases)             (decreases) 
 
↓ 
 
Aldosterone (decreases) 
 
  
   *      Deoxy corticosterone (DOC) increased in third trimester  
   *  Atrial natriuretic peptide (ANP) increased in women with preeclampsia . It 
is vaso active and promotes sodium and water excretion by inhibiting 
Aldosterone , Renin activity, Angiotensin II and Vasopressin. 
  * Increase   in   ANP   causes   increased    cardiac output  and  decreased 
Peripheral vascular resistance in response to volume expansion.  
FLUID AND ELECTROLYTE CHANGES: 
Increase in volume of ECF 
MECHANISM:- 
Endothelial injury causing proteinuria and   Decreased plasma oncotic 
pressure causing  filtration imbalance .This leads to  displacement of intra 
vascular fluid to interstitium.  
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KIDNEY: 
The characteristic renal pathology is glomerular enlargement with resultant 
ischemia. 
 
 
 Various results of the studies regarding renal vascular system in preeclampsia  
is given below. 
     *  Williams & Chesley 1945- decreased creatinine clearance 
     *  (Taufield & associates 1987)  decrease urinary excetion of Calcium 
because of increase tubular reabsorption.  
    *  Pritchard & colleagues (1984) – increase Plasma creatinine (upto 2-3mg / 
dl)    
    *  Lee & associates (1987)  oliguria despite normal left ventricular filling 
pressures and Urine sodium concentration increased.     
    *  Krishnan & co workers (1988) infused i.v dopamine into oliguric women 
with preeclampsia and  found increased urine output,increased Fractional 
Na+ excretion, increased free water clearance. 
PROTEINURIA:- 
1. Meyer & colleagues (1994) – proteinuria quantification by dipstick was not 
accurate and recommended 24 hour measurements. 
2.Adelberg & coworkers (2001) – urine protein quantification in 8 and 12 hour 
Parameters Renal blood 
flow 
Glomerular 
filtration rate 
 
Plasma uric acid 
 
Normalpregnancy 
 
Increased 
 
Increased 
 
Normal 
 
Preeclampsia 
 
Decreased 
 
Decreased 
 
Increased 
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samples correlated when there was mild to moderate proteinuria. 
3. Neihardt colleagnes (2002) & Rodriguez Thompson & Lieberman (2004) 
Found urinary protein creatinine ratio to predict significant proteinuria is good / 
suitable. 
WHAT IS PROTEINURIA? 
Increased permeability to most large molecular weight proteins thus 
abnormal albumin excretion accompanied by other proteins such as hemoglobin, 
globulins  and  transferrin. 
ANATOMICAL CHANGES: 
Using Light Microscopy Sheehan (1950) noted the following changes  
1) Glomeruli  were enlarged by 20% 
2) Capillary loop were contracted  
3) Endothelial cells are swollen  
ELECTRON MICROCOPY:- 
The following changes were noted 
1) Glomerular capillary endotheliosis  
( by spargo & associates 1959 ). 
2) The swollen endothelial cells block the capillary lumen.  
3) Homogenous deposits of an electron dense substance are  
    found between basal lamina  and endothelial cells and also within   
    endothelial cells. 
 IMMUNOFLOURESCENT STAINING:- showed  deposits of fibrinogen in biopsy 
specimen. Deposits disappear in first week postpartum. 
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 LIVER:- 
Hepatic changes in women with fatal eclampsia (by virchow) 
   1) Regions of periportal hemorrhage in liver periphery. 
   2) Sheehan & lynch (1973) found infarction accompanied haemorrhage in 
50% cases.   
   3) Elevated serum hepatic transaminase levels (Pritchard & colleagues) 
1954.  
  4) Subcapsular hematomas - patient presents with epigastric or subcostal 
pain caused by stretching of liver capsule  
   5) Hepatic rupture  
BRAIN:-  
Anatomical pathology: - Two types 
1) Gross Haemorrhage due to rupture of arteries caused by severe 
hypertension. 
2) Haemorrhage – may be wide spread or focal haemorrhagic lesions with 
edema, hyperemia, ischemia, thrombosis. 
CEREBRAL BLOOD FLOW:- 
Non invasive transcranial doppler ultrasonography - Measures Cerebral 
blood flow. Thereby cerebral perfusion pressure is calculated. 
Belfort associates (1999) 
Preeclampsia is associated with increased cerebral perfusion pressure 
counter balanced by increased cerebral vascular resistance   and no net 
change in cerebral blood flow. 
Eclampsia  Loss of auto regulation of  CBF leading to hyper perfusion. 
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BLINDNESS:- 
Otherwise Called Amaurosis (Greek work – dimming) Follows eclamptic 
convulsion in 10% women. CT  scan  shows extensive occipital lobe vasogenic 
edema. Blindness develop upto a week or more following delivery. Blindness 
lasts from 4 hours to 8 days but it resolved completely 
inall cases.  
 RETINAL DETACHMENT:- 
May also cause altered vision, usually one sided. Prognosis is usually 
good Vision usually returns to normal within a week. 
PERMANENT VISUAL DEFECTS:- 
Permanent visual loss is due to Cerebral infarction or retinal artery 
ischemia and infarction.  
CEREBRAL EDEMA:-  
Patients  with cerebral edema presents with Lethargy , Confusion , Blurred 
vision, Coma. Symptoms are waxing & waning in nature. 
EEG :-  Abnormalities  develop within 48 hrs of seizures. Half of abnormalities 
persisted longer than 1 week but most resolved in 3 months. 
UTERO PLACENTAL PERFUSION:- 
In preeclampsia  there is Vasospasm  of uterine vessels leading to 
decreased uteroplacental perfusion which leads on to increased Perinatal 
morbidity  and mortality. 11 
 Normal Pregnancy Preeclampsia 
Mean Diameter of 
Maternal myometrial  
Spiral arterioles 
 
500 micrometer 200micrommeter 
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INDIRECT MEASUREMENTS:- 
 Conversion of 17B estradiol to dehydro androsteronesulfate occurs in 
placenta and clearance of 17B estradiol is accurate reflection of human placental 
perfusion.Normal  placental clearance rate increases with advancing pregnancy. 
In preeclampsia placental clearance decreases. 
DOPPLER VELOCIMETRY:- 
 Measurement of blood flow velocity through uterine arteries used to 
estimate resistance to uteroplacental blood flow.  Vascular resistance is 
estimated by comparing arterial systolic and diastolic velocity waveforms. During 
normal pregnancy , uteroplacental bed constitutes a low resistance circuit, and 
Doppler waveforms demonstrate continuous diastolic flow. In preeclampsia 
downstream resistance increases, diastolic velocity decreases, systolic/diastolic 
velocity ratio increases. 
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ETIOLOGY 
 Hypertensive disorders due to pregnancy are more likely to develop in 
women who  
1) Are exposed to chorionic villi for the first time. 
2) Are exposed to a super abundance of chorionic villi as with twins   or 
hydatidiform mole.  
3) Have preexisting vascular disease. 
4) Are genetically predisposed to hypertension developing during 
pregnancy. 
Sibai    studied plausible potential causes as 31 
1) Abnormal trophoblastic invasion of uterine vessels.  
2) Immunological intolerance between maternal   &  fetoplacental tissues. 
3) Maternal maladaptation to cardiovascular or inflammatory changes of 
normal pregnancy. 
4) Dietary deficiencies. 
5) Genetic influences.  
ABNORMAL TROPHOBLASTIC INVASION:- 
- In normal implantation the uterine spiral arteries undergo 
extensive remodeling as they are invaded by endovascular 
trophoblasts. 
- In preeclampsia there is incomplete trophoblastic invasion. 
- Decidual vessels but not myometrial vessels are lined with 
endovascular trophoblasts.  
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ELECTRON MICROSCOPY: - 30 
Electron microscopy reveals the following changes 
1. Endothelial damage and insudation of plasma consituents into vessel 
walls, proliferation of myointimal cells and  medial necrosis. 
2. Lipid accumulates in myointimal cells and then in macrophages leading to 
atherosis.  
3. Obstruction of spiral arteriolar lumen by atherosis causing Impaired 
placental blood flow which in  turn  causes preeclampsia syndrome  
IMMUNOLOGICAL FACTORS:- 
1. Labarrer 1988 - Maternal placental interface shows microscopic changes 
suggestive of acute graft rejection. 
2. Risk of preeclampsia - decreased formation of blocking antibodies to 
placental antigens. Various possible etiological theories are listed below 
3. In First pregnancy there is  increased risk  because  effective immunisation 
by previous pregnancy is lacking.  
4. In Multiple pregnancy the  number of antigenic sites provided by placenta 
unusually great.  ( Beer 1978) 
5. In Abortion  prior immunisation  does not occur. (Crick land & associates)   
6. Immune maladaptation  - Dekker sibai (1998) 
7. Decreased Helper T cells - Bardegueze associates (1991) 
8. Th1/Th2 imbalance  (t-helper cells1/t helper cells2) - Yoneyama coworkers     
9. Th2 predominance  may be mediated by adenosine in preeclampsia. 
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THE VASCULOPATHY AND THE INFLAMMATORY CHANGES:- 
 Redmann and colleagues (1999) found that endothelial dysfunction 
associated with preeclampsia can result from “a generalized perturbation of the 
normal. Generalized maternal intravascular inflammatory adaptation to 
pregnancy.” 
 Cytokines like TNF  alpha and interleukins are released during  
oxidative stress which in turn produces reactive oxygen species and free  
radicals. These toxic radicals modify Nitric oxide production, interfere 
prostaglandin imbalance  and  injure endothelial cells.  22                  
 Treatment with Antioxidants is useful. 
EXAMPLES OF ANTIOXIDANTS:- 
They include  Vitamin E (Alpha - tocopherol), Vitamin C (Ascorbic acid), 
Beta Carotene. 
NUTRITIONAL FACTORS:- 
Studies have shown that supplements of zinc, calcium, magnesium can 
prevent  preeclampsia,        
Vitamin C deficiency  increases the  incidence of preeclampsia. 
 In Obesity there is increased production of  C - reactive protein an 
inflammatory marker  which is associated with increased incidence of 
preeclampsia 
GENETIC FACTORS:- 
1) Kipatrick associates (1989) found  an  association between HLA – DR4 
and proteinuric hypertension. 
2) Half and associates (1992) revealed that  maternal humoral response 
directed against fetal anti–HLA–DR  immunoglobulin antibody might 
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influence the development of gestational hypertension. 
3) FactorV leiden  mutation consists of an aminoacid substitution  of 
glutamine for arginine at position 506 in the factor v molecule   causing 
thrombosis of maternal myometrial vessels. 
4) ANGIOTENSINOGEN 
A molecular variant of angiotensinogen(angiotensinogen gene T 235) has 
been described in association with preeclampsia. It increases the risk of 
developing preeclampsia by a factor of 20.33 
Women heterozygous for Angiotensinogen gene variant T 235 is 
associated with increased incidence of preeclampsia & fetal growth restriction.      
PATHOGENESIS:- 
VASOSPASM:- 
The concept of vasospasm was advanced by volhard (1918) based on 
direct observation of small blood vessels in nail beds, ocular fundi and bulbar 
conjunctiva. Endothelial cell damage causes interstitial leakage causing Platelets 
and fibrinogen to be deposited sub endothelialy. 22  
ENDOTHELIAL CELL ACTIVATION:- 
* Endothelial cell activation has become the center piece in the 
contemporary understanding of the pathogenesis of preeclampsia. 
* Intact endothelium has anticoagulant properties and   it also blunts the 
response of vascular smooth muscle to agonists by releasing Nitric Oxide. 
* Damaged endothelial cell secretes substances that promote coagulation 
& increased the sensitivity to vasopressors. 
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INCREASED PRESSOR RESPONSES:- 
Normally, pregnant women develop refractoriness to infused vasopressors. 
Women with preeclampsia have increased vascular reactivity to infused 
norepinephrine & angiotensin II . 4,33 
 
PROSTAGLANDINS:- 
1. PG I2 production decreased in preeclampsia which promotes platelet 
aggregation 
2. Thromboxane A2   increase also promotes platelet   aggregation 
3. Prostacyclin, Thromboxane A2  ratio decreases and net result is increased 
sensitivity to angiotensin. 
NITRIC OXIDE: 
1. Nitric oxide is a potent vasodilator synthesized from                     
L-Arginine by endothelial cells. 
2. Inhibition of Nitric Oxide synthesis increases MAP, decreases Heart rate 
and reversed the pregnancy induced refractoriness to vasopressors. 
3. Nitric oxide is the compound that maintains the normal low pressure 
vasodilated state characteristic of fetoplacental perfusion. 
4. Nitric oxide is also produced by fetal endothelium  
5. Increased in 1. Preecalmpsia   2.  Diabetes  3.  Infection  . 
6. Nitric oxide production is increased in response to a compensatory 
mechanism for the increased synthesis and release of vasoconstrictor  
and platelet aggregating agents. 
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ENDOTHELINS:- 
 Endothelin is a potent vasoconstrictor. It is Produced in  endothelium. 
Plasma Endothelin I is increased in Normotensive pregnant women. In 
preeclampsia there is marked increase in plasma endothelin 1. Source of plasma 
endothelin 1 is systemic endothelial activation. Treatment with Magnesium sulfate 
decreases Endothelin 1 concentration. 
 
ANGIOGENIC FACTORS: 
1.VEGF – Vascular Endothelial Growth Factor. Increased in  normal pregnancy 
2. PIGF – Placental Growth Factor                                                                                                 
FUNCTIONS:  
a) Promote angiogenesis  
b) Induce Nitric oxide and  vasodilatory prosta glandin 
 VEGF is markedly increased in women  with preeclampsia but its 
bioavailability is decreased. 
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PREDICTION AND PREVENTION 
PREDICTION:- 
1. ROLL OVER TEST: Gant & colleagues (1974)    
 A hypertensive response induced by having a women at 28 – 32 weeks 
assume the supine position after lying laterally recumbent predicted gestational 
hypertension. Women with positive  roll over test is also found abnormally 
sensitive to infused angiotensin II. 
2. URIC ACID:- 
 Elevated serum uric acid levels due to decreased renal urate excretion 
found in woman with preeclampsia. Jacobson & Colleagues (1990) – found that 
Plasma uric acid values  > 5.9 mg /dl at 24 weeks has positive predictive value of 
33%  for preeclampsia. Weerasekera & petris (2003) found no significant 
increase in serum uric acid levels. 
3. FIBRONECTIN:- 
 Endothelial cell activation is likely the cause for elevated serum cellular 
fibronectin levels.  
4. COAGULATION ACTIVATION:-  
    * Thrombocytopenia and platelet dysfunction are integral features of 
preeclampsia. 
    * Increased destruction causes platelet volume to increase.  
    * High platelet volume denotes impending preeclampsia. 
    * In normal pregnancy  fibrinolytic activity decreased due to increase in 
plasminogen activator inhibitor 1 and 2. 
    * In Preeclampsia plasminogen activator inhibitor (PAI 1) increase relative to 
PAI 2 because of endothelial dysfunction. 
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5. OXIDATIVE STRESS:- 
 Increase in lipid peroxides and decrease in antioxidants causes 
preeclampsia. 
Lipid peroxides :  Malondialdehyde.  
Pro oxidants :  Iron, transferrin, ferritin, blood lipids 
including triglycerides, freefatty acids &  
lipoproteins. 
Anti Oxidants :  Vitamin – C & Vitamin – E 
Increased serum homocysteine  in mid pregnancy shows 4 fold increase 
risk of preeclampsia. Homocysteine levels are influenced by folic acid 
supplementation.(Power & associates 2003) 
CYTOKINES:- 
Interleukins and    TNF Alpha  increased. 
PLACENTAL PEPTIDES: Certain hormones are increased in preeclampsia  
which is given below. 
MARKERS OF PREECLAMPSIA: 1 Corticotropin releasing hormone, 
Chorionic gonadotropin, Activin – A, Inhibin – A 
FETAL DNA:- 
 Identification of fetal DNA in maternal serum may be predictive of 
preeclampsia. 
 
UTERINE ARTERY DOPPLER VELOCIMETRY: 
Measurement of ultra placental vascular resistance during  doppler ultra 
sound evaluation of uterine artery impedance in second trimester. 
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PREVENTION:- 
DIETARY MANIPULATION: 
Knuist & Colleagues (1998) showed that sodium restricted diet is 
inefficient in preventing  preeclampsia . Low dietary ca+ is associated with 
increased incidence of Gestational Hypertension. 14 randomised Trials with 
prenatal ca+ supplementation showed significant reduction in blood pressure in 
preeclamptics. 
Fish oil capsules – to modify prostaglandin balance may be tried. 
LOW DOSE ASPIRIN:- 
 60 mg aspirin to reduce the incidence of preeclampsia ineffective. Asprin 
suppress thromboxane suppression  and thereby decreased platelet aggregation, 
increase  prostaglandin-I2 production, also increased the incidence of placental 
abruption. 
ANTIOXIDANTS:  Chappel & colleagues found that Vitamin C (1000 mg / day) & 
Vitamin E (400 mg/day) versus placebo showed significant decrease in 
endothelial cell activation in preeclampsia. 
EARLY PRENATAL DETECTION:- 
1. Increase prenatal visits during 3rd trimester  helps in early detection. 
2. Women with BP > 140 / 90mmHg should be admitted and evaluated. 
3. Women with diastolic BP > 81 – 89 mmHg with weight gain > 2 pounds / week 
in 3rd trimester were asked to visit at every 3-4 days interval. 
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INVESTIGATIONS 
1. Hemoglobin and hematocrit 
2. Platelet count 
3. Quantification of protein excretion 
4. Serum creatinine 
5. Serum uricacid 
6. Serum transaminase levels 
7. Serum albumin 
8. Serum lactic acid dehydrogenase levels 
9. Blood smear 
10.Coagulation profile 
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MONITORING 
Monitoring of preeclamptic patients can be classified into two groups as 
follows 
A) NON INVASIVE MONITORING: 
Is required for all cases 
1. Oxygen saturation 
2. Automated blood pressure and pulse monitoring 
3. Foleys catheter for urine output 
4. Fetal heart rate monitoring. 
B) INVASIVE MONITORING 
1. Arterial line is mandatory for  
a) Morbidly obese woman 
b) Refractory hypertension where sodium nitroprusside is 
necessary 
c) Pulmonary edema where serial blood gas measurements are 
necessary 
2. Central venous pressure monitoring is required for severa preeclamptic    
    patients with oliguria 
3. Pulmonary arterial line is mandatory if 
a) If initial CVP reading is high (8 or above) 
b) Oliguria persists even with normal central venous pressure 
                     c) Pulmonary edema 
          d) Cardiovascular collapse 
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TREATMENT STRATEGY OF PREECLAMPSIA 
ANTEPARTUM HOSPITAL MANAGEMENT: 
1) Detailed examination followed by daily scrutiny for clinical findings such as 
headache, Visual disturbances, epigastric pain, rapid weight gain. 
2)  Weight on admittance and everyday thereafter. 
3) Analysis for proteinuria on admittance every 2days there after. 
4) BP readings in sitting position with an appropriate size cuff every 4 hours 
except between midnight and morning. 
5) Measurements of Plasma or serum creatinine, hematocrit, platelets, serum 
liver enzymes.  
6) Frequent evaluation of fetal size and amniotic fluid volume either clinically 
or by ultra sonography. 
7) Reduced physical activity throughout the day 
8) Ample but not excessive protein included is diet.  
Further management depends upon.14 
• Severity of preeclampsia, determined by presence or absence of 
conditions cited.  
• Duration of gestation. 
• Condition of cervix.  
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MANAGEMENT:- 
BASIC MANAGEMENT OBJECTIVES:- 
a. Termination of pregnancy with the least possible trauma to mother 
& fetus. 
b. Birth of an infant who subsequently thrives. 
c. Complete restoration of health to the mother. 
TERMINATION OF PREGNANCY:-  
Regardless of gestational age any of the following complications mandates 
immediate delivery 
1. Severe hypertension that persists after 24- 48 hours 
2. Progressive thrombocytopenia 
3. Liver dysfunction 
4. Progressive renal dysfunction 
5. Premonitory signs of eclampsia 
6. Evidence of fetal jeopardy. 
DELIVERY IS THE CURE FOR PREECLAMPSIA. 
Non stress test or Bio physical profile for fetal assessment measurement 
of  lecithin sphingomyelin ratio in amniotic fluid is an evidence of lung maturity. 
Labour  is induced by intravenous oxytocin, Cervical ripening with  prostaglandin 
or osmotic dilator. If  labour induction failed cesarean delivery.  
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ANTI HYPERTENSIVE DRUG THERAPY:- 
Study  Prolongation pregnancy Severe HT 
Cesarean 
Delivery 
200 pts. 
Sibai eta1 
Labetatol 
(100) 20.1 5 36 
 Placebo (100) 21.3 14 32 
Study Abruptio Mean birth wt Growth restriction 
Neonatal 
breaths 
Sibai eta1 2 2205 19 1 
200 pts. 0 2260 9 0 
 
“Growth restricted infants were twice as frequent in women given labetalol 
compared with those treated by hospitalization alone. 
. 
ECLAMPSIA  
Preeclampsia complicated by generalized clonic tonic  convulsions is 
termed Eclampsia . 
COMPLICATIONS:- 
1) Abruption of placenta (10%) 
2) Neurological deficits (7%) 
3) Aspiration Pneumonia (7%) 
4) Pulmonary Edema (8%) 
5) Cardio pulmonary arrest (4%) 
6) ARF (4%) 
7) Maternal death (1%) 
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CLASSIFICATIONS:- 
1) Ante partum 
2) Intra partum 
3) Post partum 
DESCRIPTION OF CONVULSIVE ATTACK: 
1) Convulsive movements begin about the mouth in the form of facial 
twitchings.  
2) After a few seconds the entire body become rigid in a generalized 
muscular contraction – phase 15 – 20 secs. 
3) Suddenly jaws open & close violently & soon after the eyelids as well. 
    Other facial muscles & then all muscles alternately contract &  
    relax in rapid succession. 
    So forceful are the contractions that woman may throw herself   
    out her bed & if not protected. Her tongue is bitten by violent  
    action of the jaws. This phase last about a minute. 
4) Gradually the muscular movements become smaller and less frequent , 
finally woman lies motionless. 
5) Throughout the seizure the diaphragm has been fixed, with respiration 
halted.  
For a few seconds the woman appears to be dying from respiratory arrest, 
but then she takes a long, deep stertorous inhalation & breathing is 
resumed. 
6) Continuous convulsions – status epilepticus. 
7) After a seizure  coma ensues – overtime memories return. 
* Respiration increased in rate 50 or more / min after a convulsion  to combat 
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hypercarbia from lactic academia.  
* cyanosis  
* High fever is a grave sign for CNS hemorrhage. 
Antepartum eclampsia labor may begin spontaneously after the convulsion 
ensue & progress rapidly.   
If convulsions occur during labor   contractions may increase in frequency 
and intensity & duration of labor may be shortened.  
   *  Fetal bradycardia  from maternal hypoxemia recovers in 3 – 5  
          minutes 
   *  Pulmonary edema is  caused by aspiration pneumonitis,  from inhalation of 
gastric contents if vomiting accompanies convulsions.  
   *  Cerebral hemorrhage is  due to ruptured berry aneurysm or arteriovenous 
malformation.   
  *  Blindness occurs in 10% of patient due to  occipital lobe ischemia and  
retinal detachment. 
   *  Psychosis   lasts several days to 2 weeks. 
“Until proved other wise all pregnant women with convulsion should be 
considered to have eclampsia.”  
PROGNOSIS:- 
Prognosis – 10 – 15% mortality rate 
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TREATMENT STRATEGY OF PREECLAMPSIA 
MAGNESIUM SULPHATE THERAPY  
DOSAGE SCHEDULE FOR SEVERE PREECLAMPSIA AND ECLAMPSIA:- 
1) CONTINUOUS INTRAVENOUS INFUSION:- 
a) Give 4 – 6 g loading dose of magnesium sulfate diluted in 100ml of IV fluid 
administered over 15 20 min. 
b) Begin 2g/hr in 100ml of IV maintenance infusion. 
c) Measure serum magnesium level at 4 – 6 hr and adjust infusion to maintain 
levels between 4 – 7 Meq / l. 
d) Magnesium sulfate is discontinued 24 hr after delivery. 
2) INTERMITTENT INTRA MUSCULAR INJECTIONS:- 
 a) Give    4gm    of    Mgso4. 7H2O    USP     as     20%     solution intravenously 
at a rate not to exceed 1 gm / min. 
b) Follow  promptly  with  l0g  of 50% Mgso4 solution, one half (5g)   injected   
deeply   in   upper   outer   quadrant of both buttocks through a 3 inch long, 20 
guage neddle.  
If  convulsions   persists   after   6 min,   give up to  2g  more intravenously 
20% solution at a ratr not to exceed l g/min. 
3) Every  4 hr  thereafter  give  5g  of  50%  solution  of  Mgso4.7H2O injected 
deeply in the upper outer quadrant of alternate buttocks. 
 Ensure that  
a) Patellar reflex is present. 
b) Respirations not depressed.  
c) Urine output in the pervious 4 hour exceeded 100ml. 
4) Magnesium    sulfate    is   discontinued   24 hr   after   delivery. 
    Magnesium   sulfate   is   not   given   to   treat   hyper   tension. 
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PHARMACOLOGY & TOXICOLOGY OF MAGNESIUM SULFATE:- 
   * Magnesium sulfate USP is Mgso4.7H2O & not Mgso4. 
   * Parenteral Magnesium is cleared almost by renal excretion.  
   *  Plasma Magnesium level to prevent eclampsia 4 – 7 Meq / l. 
   *  Plasma Magnesium 10 Meq / l - patellar reflexes disappear presumably 
because of curarie form action.  
   *  Plasma Magnesium > 10 Meq / l - respiratory depression. 
   *  Plasma Magnesium > 12 Meq / l - Respiratory paralysis &  
          arrest  
   * Antidote to Mgso4.H2O is Calcium gluconate  
Dose : 1gm IV 
Action Short lived.  
Patient with respiratory depression  requires tracheal intubation  and mechanical 
ventilation. 
 Benefcial effects of magnesium sulfate  
1) It has an inhibitory effect at the neuro muscular junction. 
2) Both invivo and invitro studies found magnesium to increase production of 
endothelial vasodilator prostacyclin. 
3) Protects against ischemic damage of cells by substitution of calcium and 
also prevents entry of ca++ ions into ischemic cells. 
4) Anticonvulsant by acting as a NMDA receptor (N – methyl – D – aspartate) 
antagonist  
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Effect of Increasing plasma magnesium levels:- 
Plasma mg (meq/l) Effects 
1.5 – 2.0 Normal plasma level 
4.0 – 8.0 Therapeutic range 
5.0 – 10 ECG changes  
(PQ interval prolonged, QRS complex 
widens) 
10 Loss of deep tendon reflexes. 
15 Sinoatrial and atrioventricular block, 
respiratory paralysis.  
25 Cardiac arrest 
 
UTERINE EFFECTS:- 
 Mg ++ ions in high concentrations may depress myocardial contractility 
both invivo and  invitro.  
FETAL EFFECTS:- 
 Magnesium crosses placenta and  achieve equilibrium in fetal serum. 
Neonatal depression  occurs only if  there was severe hypermagnesemia at the 
time of  delivery. Small but significant decrease in fetal heart rate variability. 
MATERNAL MORTALITY IN ECLAMPSIA- TRIAL COLLABORATIVE GROUP 
MORTALITY. 
Regimen No Maternal (%) 
Perinatal (per 
1000) 
Magnesium 
sulfate 
453 3.8 25 
Diazepam 452 5.1 22 
phenytoin 387 5.2 31 
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ANTI HYPERTENSIVE DRUG THERAPY:- 
Rational:-  
1) Prevent maternal morbidity associated with 
a) Encephalopathy b) CVA   c) End organ damage 
Threshold for treatment of Diastolic BP is 105 – 110 mmHg   
 MAP – 125 mmHg 
HYDRALAZINE TO CONTROL SEVERE HYPERTENSION:- 
 Hydralazine is given when  Systolic BP > 160 mmHg  and Diastolic BP 
>110 mmHg . Dosage: 5 – 10 mg doses is given  at 15 – 20 min intervals until 
Diastolic BP decreased to 90 – 100mmHg. Fetal bradycardia is the expected 
complication . Hydralazine is the most commonly used drug. It Decreases 
episodes of  acute blood pressure increases in pregnancy.  It relaxes arterioles 
and decreases systemic vascular resistance through increased Cyclic AMP  
Action:-   
1) HR, SV, CO increased. 
2) Increased uterine perfusion  
LABETALOL :  
 It is an Alpha 1  and nonselective Beta blocker. (1:3 orally, 1:7 iv) .It is a 
second line drug. Decreases maternal SVR with out increased HR. Intravenous  
labetalol lowered BP more rapidy and  associated tachycardia was minimal. Initial 
dose is 10mg then increased by 10 mg every l0 minutes NHBPEP (2000) 
recommends starting with 20 mg iv bolus then 40mg with in 10 minutes then 80 
mg every 10 mins. Not to exceed 220 mg total dose per episode treated. Recent 
work – labetalol 1 mg / kg will decrease maternal blood pressure with out 
affecting the intervillous and fetal blood flow. Avoided in CHF / Asthma. 
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NITRO GLYCERINE: 
* Rapid onset  
* Produces abrupt hypotension 
* Sublingual 400 microgram 
Mechanism of action: 
  It produces  Vascular smooth muscle relaxation by intracellular 
degradation to Nitric oxide , Increased C-Gmp and venous relaxation , decreased 
pre load . 
NIFEDIPINE :- 
Decreased influx of ca+ smooth muscles  
Advantages:- 
1) They act as vasodilator. 
2) Uterine muscle relaxants. 
3) Increased Renal Blood Flow. 
4) It readily crosses placenta. 
5) In severe preeclampsia it decreases maternal BP  and prolongation 
of pregnancy and improvement of fetal oxygenation.  
Nifedipine 10 mg oral dose repeated in 30 mints 
Complications:- 
I. Severe Refractory Hypertension:  It can be treated with a) Mgso4 
b) IV labetalol & IV hydralazine. 
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SODIUM NITROPRUSSIDE 
Nitroprusside is used unless there in no response to hydralazine, labetalol, 
nifedipine. Continuous infusion with dose of 0.25 micro gram / kg / min increased 
to 5 micro gram/ kg / min.  
Mechanism of action:- 
Sodium nitroprusside interact with sulph hydryl group on endothelium and 
releases Nitric oxide to relax arterial vessels.  
Dose: 0.5 microgram / kg / min. Production of cyanide > 4 microgram / min 
Fetal cyanide toxicity may occur after 4 hour. 
Persistent Immediate severe post partum Hypertension due to two causes:-  
MECHANISMS:- 
1) Underlying chronic hypertension. 
2) Mobilisation    of    edema    fluid    with    redistribution    into  the 
intravenous compartment  
Labetalol and diuretic is effective treatment for both mechanisms. 
DIURETICS & HYPER OSMOTIC AGENTS:- 
Diuretics can compromise placental perfusion and produces  intravascular 
volume depletion It is used only in case of pulmonary edema. Once delivery 
occurs there is spontaneous diuresis that usually begins with in 24 hours and 
disappearance of excessive extra vascular fluid over the next 3 – 4 days. 
Hyper osmotic agents infusion shows appreciable intra vascular influx of 
fluid and escape of intra vascular fluid in the form of edema to vital organs like 
lungs, brain. 
OTHER HYPERTENSION AGENTS:-   NHPEP (2000) 
Verapamil iv infusion 5 – 10 mg / hour. MAP lowered by 20% 
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ANATOMICAL CHANGES OF VERTEBRAL COLUMN 
DURING PREGNANCY 
 
The following are the changes in vertebral column during pregnancy. 
1. Uterine enlargement and vena caval compression result in engorgement of 
epidural veins. 
2. Unintentional intravascular cannulation and injection of local anesthetic are 
more common in pregnant patients. 
3. Vertebral foraminal veins which are contiguous with the epidural veins are 
enlarged and obstruct the pathways for local anesthetic to exit. 
4. Enlarged epidural veins may displace cerebrospinal fluid from the 
thoracolumbar region of subarachnoid space as does the increased 
intraabdominal pressure of pregnancy. This explains the lowered dose 
requirement of pregnancy. 
5. Subarachnoid dose requirement are also affected by the lower specific gravity  
of cerebrospinal fluid in pregnant patients as compared with nonpregnant 
patients. 
6. The hormonal changes of pregnancy affect the perivertebral ligamentous 
structures including ligamentum flavum. 
7. Ligamentum flavum may feel lessdense and softer in pregnant woman than in 
non pregnant woman. It is therefore difficult to feel the movement of needle 
through the ligamentum flavum. 
8. It is more difficult for a pregnant women to achieve flexion of the lumbar 
spine.progressive accentuation of lumbar lardosis alters the surface anatomy 
of vertebral column in two ways. 
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a) A pregnant woman pelvis rotates along the long axis of the spinal column 
thus the line joining the iliac crest assumes a more cephalad relationship to 
the vertebral column. 
b) Imaginary line might cross the vertebral column at L3-L4 interspace rather 
than L4-L5 interspace. 
9. Less space exists between adjacent lumbar spinous process during 
pregnancy. Mid line approach is difficult. 
10. MRI has shown that apex of the lumbar lordosis is shifted cauded during 
pregnancy and typical thoracic kyphosis in pregnant women. 
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ADVANTAGES OF SPINAL ANESTHESIA 
Spinal anesthesia has the following 
1. Simplicity 
2. Rapid onset in cases of fetal distress 
3. Dense neural blockade 
4. Negligible maternal risk  of systemic local anesthetic toxicity 
5. Minimal transfer of drug  fetus 
6. Well suited for emergency cesarean section. 
  
DISADVANTAGES OF SPINAL ANESTHESIA 
Though spinal has many advantages over epidural and general anesthesia 
it has some disadvantages also which are depicted below. 
1. Rapid onset of sympathetic blockade produces abrupt severe 
hypotension 
2. Hypotension may not be tolerated by a fetus with evidence of chronic 
compromised uteroplacental perfusion 
     ( IUGR, oligohydramnios ) 
3.  When surgery is longer than anticipated supplemental  analgesia or 
change over to general anesthesia may be required. 
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ADVANTAGES OF EPIDURAL ANESTHESIA 
The following are the advantages of epidural anesthesia. 
1.  Local anesthetic agent can be administered in incremental doses and that 
the total dose can be titrated to desired level. 
2.  Slower onset of anesthesia, therefore allows maternal cardiovascular 
system to compensate for the occurrence of sympathetic blockade, 
decreased risk of hypotension, decreased risk of reduced uteroplacental 
perfusion. 
3.  Can maintain anesthesia regardless of the duration of surgery. 
4.  Lower extremity muscle pump remain intact and reduced incidence of 
thromboembolic disease. 
5. Opioid or a local anesthetic may be given through a epidural catheter. 
 
DISADVANTAGES OF EPIDURAL ANESTHESIA 
Disadvantages of epidural ansthesia is given below. 
• Slow onset in case of fetal distress is disadvantageous in case of fetal 
distress. 
• Anesthesiologist must wait for 3-5 minutes before giving therapeutic dose. 
• 10-20 minute  period is required for adequate surgical anesthesia. 
• Post dural puncture headache is more after accidental dural puncture. 
• Epidural catheter may migrate into a blood vessel during labour or surgery. 
• Increased systemic absorption of local anesthetic results in greater 
placental transfer o drug to fetus than spinal  anesthesia. 
• Large amount of local anesthetic required , therefore systemic toxicity may 
be high. 
• Unintentional subarachnoid injection of a large dose of local anesthetic 
results in high or total spinal anesthesia.  
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GENERAL ANESTHESIA –DISADVANTAGES 
 Apart from the common complications like aspiration in general anesthesia 
for cesarean section there are some unique complications in preeclamptic 
patients  
1. Gross airway edema causing increased incidence of difficult 
intubation. 
2. Hypertensive response to laryngoscopy . 
3. Stress response increases intracranial pressure and chances of 
intracerebral hemorrhage is more. 
4. Drug interaction to antihypertensives and magnesium sulphate can 
occur. 
5. Hodgkins et al reported that Systolic blood pressure  and PCWP 
increases significantly in preeclamptic women during intubation , 
suction , and extubation under general anesthesia  
6. Impairment of inter villous blood flow. Thetefore uterine bloodflow is 
very much reduced 
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SUPINE HYPOTENSION SYNDROME 
  IN 15% of patients     supine position results in signs of shock including  
hypotension, pallor, vomiting and decerebration. This is called as supine 
hypotension syndrome. Inferior venacava compression results in pooling of 
venous blood and increased uterine and lower extremity venous pressures. 
UTERINE PERFUSION PRESSURE = UTERINE ARTERY PRESURE-UTERINE  
VENOUS PRESSURE 
• Uterine artery pressure is decreased secondary to decreased cardiac 
output. 
• Uterine venous pressure is increased with aortocaval compression. 
• Supine position should be avoided by pregnant woman at term. 
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USE OF VASOPRESSORS IN SPINAL ANESTHESIA 
EPHEDRINE USAGE IN SPINAL ANESTHESIA 
EPHEDRINE:- It is  an indirect acting catecholamine that stimulates alpha and 
beta adrenergic receptors. 
MECHANISM OF ACTION 
It acts through 
1. Endogenous release of norepinephrine- (indirect action) 
2. Direct action adrenergic receptors. 
USES: 
Ephedrine 10 to 25 mg i.v is the most commonly selected 
sympathomimetic when drug therapy is required to increase blood pressure in the 
presence of sympathetic nervous blockade produced by regional anesthesia or 
hypotension due to inhaled or injected anesthetics. 
ADVANTAGE OF EPHEDRINE IN PREGNANCY: 
Uterine blood flow is not altered when used in pregnant patients under 
subarachnoid blockade for cesarean section. 24,25,26,27 28, 29 
CARDIOVASCULAR EFFECTS:  
1. Increase in systolic and diastolic blood pressure  
2. Increase in heart rate and cardiac output 
3. Renal and splanchnic blood flow are decreased due to alpha effects 
4. Coronary and skeletal muscle blood flow increased. 
5. Increased myocardial contractility due to activation of beta 1 receptors. 
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DISADVANTAGES: 
TACHYPHYLAXIS 
Second dose of ephedrine produces less intense systemic blood pressure 
responses than the first dose. This phenomenon is known as Tachyphylaxis. 
ETIOLOGY:- 
It is due to 
1.Persistent blockade of Adrenergic receptors 
2.Depletion of Noradrenergic stores 
It usage is contraindicated in cardiac patients 
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REVIEW OF LITERATURE 
  Wallace et al  - 1995 -a prospective study comparing general anesthesia, 
epidural anesthesia, combined spinal epidural anesthesia for cesarean section in 
severely preeclamptics showed that hypotension was slightly more in combined 
spinal epidural group but hypotension was short lasting and revertable. 
 Hood and Curry et al 1999 –a retrospective study comparing spinal 
anesthesia and epidural for cesarean section severely preeclamptics showed a 
13% decrease in mean lowest  mean arterial pressure from baseline in both 
spinal and epidural groups. 
Sushee Visalyaputra et al 2005 - studied  spinal versus epidural 
anesthesia for cesarean delivery in severe preeclampsia and showed that spinal 
anesthesia produces slightly more hypotension than does epidural anesthesia 
during the induction to delivery period.The duration of hypotension however was 
short and there was no difference in neonatal status. 
 Ramanathan J, et al studied combined spinal and epidural anesthesia with 
low doses of intrathecal bupivacaine in women with severe preeclampsia.  He 
concluded that CSE with low dose of  bupivacaine  produces adequate 
anesthesia for cesarean delivery in patients with severe preeclampsia. 
Aya et al. studied spinal anesthesia induced hypotension : a risk 
comparison between patients with severe preeclampsia and healthy women 
undergoing  preterm cesarean delivery and found that Patients with severe 
preeclampsia experience less hypotension during spinal anesthesiafor elective 
cesarean delivery than healthy parturients:  
Lee A,Ngan Kee WD  made a dose response meta  analysis of 
prophylactic intravenous ephedrine for the prevention of hypotension during 
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spinal anesthesia for elective cesarean delivery.The results showed that 
ephedrine can be used safely in preeclamptic women without adverse effects on 
both mother and fetus because ephedrine increase uterine and placental 
circulation and therefore the preferred vasopressor in preeclampsia 
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MATERIALS AND METHODS 
Study design :  This study was a randomized prospective comparative study. 
Study setting and population: 
After obtaining Institutional ethical committee clearance, the study was 
carried out on 84 patients in the operation theatre,Department of Anesthesiology, 
Tirunelveli medical college, Tirunelveli . 
In this  study we allocated the patients into two groups  
GROUP ---1  is normal group  or N group. It constitutes 43 ASA grade I patients  
 coming for cesarean section. 
GROUP---2  is preeclamptic group or PE group. It constitutes 41 ASA grade II,  
 ASA grade III preeclamptic patients coming for cesarean section.  
SELECTION CRITERIA  OF PREECLAMPTIC PATIENTS 
Patients with 
1. Systolic blood pressure>140mmHg 
     2. Diastolic blood pressure >90 mmHg   
     3. Proteinuria 
     4. Generalized edema were included in the study. 
EXCLUSION CRITERIA 
The following patients were excluded from the study 
1 Gestational diabetes mellitus 
2 Inadequate analgesia where supplementation required 
3 Blood transfusion required 
4 Any intra op complications 
5 HELLP syndrome 
6 Fetal distress 
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7 Spinal deformity 
8 Height less than 140cms 
9 Patients on anticoagulation treatment 
10 Antepartum hemorrhage 
11 Heart disease 
 
PREOPERATIVE EVALUATION 
1 History 
2 Clinical examination 
3 Urine for albumin &sugar 
4 Blood biochemistry including 
          1.  Blood sugar  
          2.  Blood urea 
          3. Complete hemogram 
Just before the operative procedure the following parameters were noted. 
1. Height 
2. Weight 
3. Gestational age 
4. Obstetric score 
5. Indication for cesarean section 
 
PROCEDURE  
Preeclampsia was diagnosed as per Standard diagnostic criteria such as 
Clinical features , Blood pressure and Laboratory Investigation .  
Premedication :-  Patients in both the groups received Inj. Metaclopromide 
10mg, Inj. Ranitidine 50mg before the procedure. 
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Both the groups received 10 ml/kg of 0.9% normal saline intravenously 
before giving Subarachnoid blockade. Subarachnoid blockade was performed 
using 23 guage Quinckes needle with the patient in right lateral position  at L3-L4 
inter space and 9mg or 1.8 ml of Hyperbaric Bupivacaine for Lower segment 
Cesarean Section. Immediately after giving  subarachnoid blockade patients 
were turned supine. A wedge with 10cms height was placed under the right hip to 
correct uterine displacement. All patients were supplemented with oxygen at 
4litres/minute. Level of blockade was T5-T6 in all tne cases . Immediately after 
delivery of the baby patients in both the groups received  Injection . Oxytocin 10 
units  intravenously and  1mg of Inj.Midazolam intravenously.  
Pulse rate, Blood pressure was monitored in both the groups before 
subarachnoid blockade, immediately after subarachnoid blockade and for every 2 
minutes interval for first ten minutes then at every 5 minute interval for a period of 
two hours.  
Temperature, ECG, SPO2, Urine output was also closely monitored in 
both the groups. 
Neonatal APGAR SCORE was recorded  at two minute and five minute 
interval in both the groups. 
 
CRITERIA FOR EPHEDRINE 
Inj. Ephedrine was used when patient developed intra operative 
hypotension with Systolic Bp < 100 mm Hg or fall  of  25% of baseline   or   mean 
arterial pressure fall of 25%  from baseline value. 
 Injection Ephedrine 6mg was used in incremental  doses. 
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RECORDED PARAMETERS FOR STATISTICAL ANALYSIS 
The following parameters were noted both intraoperatively and postoperatively 
1 Baseline BP and HR before spinal anaesthesia 
2 Maximal fall Percentage of systolic blood pressure and mean arterial 
pressure 
3 Incidence of Bradycardia and Atropine usage. 
4 Total dose of ephedrine used  
5 Total amount of fluid infused  
6 Neonatal Apgar scores@1 min, 5 min 
7 Post operative BP two hours after surgery 
Student  “t” test was used for  statistical analysis.   
 
 
 
 
 
 
 
 
 
 
 
 
 
58 
 
DEMOGRAPHIC VARIABLES 
Variable Normal 
n=43 
Pre.ec 
N=41 
P value Significance 
Age 25.28 
±3.68 
26.19 
±3.23 
0.230 P>0.05 
NS 
Weight 
Kg 
61.42 
± 6.53 
65.02 
± 6.42 
0.014 P<0.05 
S 
 
 
 
 
Age in both normal and preeclamptic group is comparable as noted by P value 
which is not significant Weight was slightly higher in preeclamptic group and P 
value is less significant. 
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TABLE SHOWING BASELINE BLOOD PRESSURE AND HEART  RATE IN 
PREECLAMPTIC GROUP AND NORMAL GROUP 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Systolic blood pressure, Diastolic blood pressure, Mean arterial 
pressure was higher in preeclamptic group and all the parameters showed  a “ p ” 
value of  < 0.001  which was highly significant. This implies that both the groups 
were of different entity. 
 
 
 
 
 
 
 
N group
N 43 
PEgroup
N 41 
P value Significance 
SBP 
123.3 
±12.7 
147.6 
± 19.3 
0.000 
P< 0.001 
HS 
DBP 
82.1 
± 11.6 
95.9 
±13.2 
0.000 
P< 0.001 
HS 
MAP 
92.7 
±9.7 
112.56 
± 15.3 
0.000 
P< 0.001 
HS 
HR 
82.5 
±12.25 
84.25 
±14.13 
0.194 
P>0.05 
NS 
60 
 
 
 
 
BASELINE BLOOD PRESSURE AND HEART RATE 
 
Bar diagram depicting systolic BP, diastolic BP,Mean arterial pressure, Heart rate 
in Normal and Preeclamptic group 
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COMPARISON OF  EPHEDRINE,  ATROPINE, FLUID REQUIREMENT IN 
BOTH GROUPS 
Variables Normal group Preeclamptic group p-value Significance 
Total 
Ephedrine in 
mg 
5.02 
± 5.39 
8.34 
± 6.42 0.012 
P<0.05 
S 
No patient req 
Ephedrine 
24/43 
56% 30/41 73%  
P>0.05 
NS 
Bradycardia 
Atropine req 
6/43 
14% 
5/41 
12%  
P>0.05 
NS 
Total IVF 1451.9 ± 118.7
1518.8 
± 151.4 0.026 
P<0.05 
S 
Apgar 1 min 7.2 ± 0.81 
7.4 
± 1.03 0.174 
P>0.05 
N S 
Apgar 5 min 
9.2 
±0.67 
 
9.4 
±0.7 0.311 
P>0.05 
NS 
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The Total dose of Ephedrine required and Total dose of intravenous  fluid 
required was higher in preeclamptic group . This small percentage of increase is 
acceptable . The occurance of Bradycardia and Atropine requirement was higher 
in normal group. 
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PERCENTAGE OF HYPOTENSION  
The maximal fall in systolic blood pressure and mean arterial pressure 
were noted in both the groups. 
 
 
N Group 
N 43 
PEGroup 
N 41 
P value 
Significance 
level 
Max fall in 
SYS BP % 
21.2 
±10.7 
24.3 
± 10.4 
0.186 
P>0.05 
NS 
Max fall in 
MAP % 
24.9 
± 13.4 
28.9 
± 11.8 
0.148 
P>0.05 
NS 
 
 
 
The maximal fall in systolic and mean  arterial pressure were noted in both 
the groups. Fall in systolic blood pressure and mean arterial pressure was the 
same in both the groups as per the statistical value. 
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HEMODYNAMIC VARIABLES AFTER TWO HOURS 
Normal group 
 
N Group 
n 43 
Baseline 
N Group 
n43 
2 h 
P value significance 
SYS BP120 
123.3 
±12.7 
118.5 
±11.1 
0.143 
P>0.05 
NS 
DIA BP 120 
82.1 
± 11.6 
77.6 
±10.8 
0.154 
P>0.05 
NS 
MAP 
92.7 
±9.7 
89.9 
±10.6 
0.151 
P>0.05 
NS 
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PREECLAMPTIC GROUP 
 
 
 
 
The Systolic blood pressure, Diastolic blood pressure and Mean arterial 
pressure returned to the baseline values in both the groups. 
 
Variables 
PE group 
n 41 
Baseline 
PE group 
N 41 
2 h 
P value Sinificance 
Systolic BP 
147.6 
± 19.3 
140.1 
±15.3 
 
P>0.05 
NS 
Diastolic BP 
95.9 
±13.2 
91.7 
±12.5 
 
P>0.05 
NS 
Mean arterial 
pressure 
112.56 
± 15.3 
108.7 
±16.2 
 
P>0.05 
NS 
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RESULTS OF THE STUDY 
In this study, in normal group the mean systolic BP is 123 mmHg , mean 
diastolic BP was 82mmHg , mean arterial pressure is 92 mmHg. In pre eclamptic 
group systolic BP, diastolic BP, mean arterial pressure is 147, 95, 112 mmHG 
respectively. Its P value is less than 0.001 which is highly significant. This 
indicates that both the groups are of different entity. 
The maximum fall in systolic BP, MAP is 21.2% and 24.9% in normal 
group compared to 24.3 % and 28.9 % in preeclamptic group . P value is also not 
significant indicating that there is no significant hypotension. 
  Regarding vasopressor requirement the amount of Ephedrine used intra 
operatively in preeclamptic group is 8.34 mg compared to 5.02 mg in normal 
group. P value is  less than 0.05 which is significant .This 3mg of increased 
Ephedrine requirement is  used without any adverse effects to the patients. 
Percentage of patients requiring Ephedrine is 73% in preeclamptic group 
compared to 56% in normal group.  
Total Intravenous fluid infused is 1518 ml in preeclamptic group compared 
to 1451 ml in normal group. Its P value is not significant.  
Brady cardia occurrence in normal group is 14% compared to 12% in 
preeclamptic group. Hemodynamic variables after two hours returned to baseline 
values in both the groups . 
APGAR score at 1 minute and 5 minute interval is 7.2 and 9.2 in normal 
group compared to 7.4 and 9.4 in preeclamptic group and reveals no adverse 
neonatal out comes.  
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DISCUSSION 
In this study patient selection criteria were determined in an attempt to 
select only severely hypertensive patients whose obstetric therapy least 
complicated interpretation of blood pressure response to spinal anesthesia. 
Labouring were excluded because they may be less likely to suffer hypotension 
during regional anesthesia for cesarean section. Also patients with diabetes, 
heart disease, patients requiring intraoperative blood transfusion were excluded 
since their cardiovascular status may be influenced by their disease pathology.  
Dosage  of Hyperbaric Bupivacaine used in this study is  9mg .Dosage 
used in Wallace et al, Aya et al ,Hood and curry et al were 11.4 mg,13.5 
mg,11mg respectively. This decreased dosage used in this study may account for 
decreased hypotension in this study. Factors such as management of 
Intravenousfluids , Antihypertensive therapy, Ephedrine usage  may contribute to 
the differences  observed in the  decrease in blood pressure. 
Ephedrine usage was 8.75 to 10mg in Aya et al study and it was 8.34 mg 
in this study. Number of patients requiring ephedrine is 23%,  32% ,72%, in Hood 
and  curry et al , Wallace et al , Sushee visalyaputra et al. In this  study it was 
73% which is comparable to other studies 
Intra venous fluid required intraoperatively for spinal anesthesia was 1780 
ml in Ayaet al and 2255 ml in Wallace eal study. In this study we have used 1518 
ml  which is comparable to the above studies 
This study shows that spinal anesthesia for cesarean section in severely 
preeclamptic patients causes slightly more reduction in blood pressure. The 
duration of hypotension was however was short and there was no difference in 
neonatal status. 
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In the prospective study by Wallace et al comparing general anesthesia, 
epidural and combined spinal epidural anesthesia for cesarean delivery in 
severely preeclamptic patients ,the mean lowest systolic arterial pressure and 
diastolic arterial pressure values after CSE technique were similar in this study. 
A retrospective study by Hood & Curry et al compared spinal anesthesia 
and epidural anesthesia for severely preeclamptic patients for cesarean delivery.  
A similar study comparing spinal and epidural anesthesia was done by sushee 
vishalyaputra et al . The results of these studies is given below. 
Study Percentage of fall in MAP 
in spinal anesthesia 
Percentage of fall in MAP 
in epidural anesthesia 
Sushee visalyaputra et al 51% 23% 
Wallace et al 25% 25% 
Hood and curry et al 13% 13% 
This study 24% - 
 
In this study the fall in Mean Arterial Pressure is comparable to other 
studies. There is no significant hemodynamic changes induced by spinal 
anesthesia in preeclamptic patients and neonatal out comes assessed by 
APGAR score was normal as compared other studies. 
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SUMMARY 
 
This study summarises that spinal anaesthesia in Normal and 
Preeclamptic groups 
1) Does not alter the hemodynamic variables. Although the incidence was 
slightly more frequent in preeclamptic group , the hypotension is short 
lived and easily correctable without imposing any danger to both the 
mother and the fetus. 
2) Neonatal outcome was same in both the groups 
3) Vasopressor requirement and Total intravenous fluid infused was 
marginally raised but adding 3 mg of Inj.Ephedrine  in addition is quiet 
acceptable. 
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CONCLUSION  
1) Spinal Anesthesia does not produce gross haemodynamic changes in Pre 
eclamptics 
2) SAB can be safely practiced in pre eclamptic for LSCS 
3) The benefit of Rapid, dense and reliable SAB over epidural anaesthesia 
should be considered for preeclamptics undergoing cesarean section. 
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PROFORMA 
 
STUDY – Spinal anesthesia in Preeclamptic Vs Normal patients for LSCS 
 
Name :     Age:  Ht:  Wt: 
I.P.No:  Unit:   Date:  
 
Obstetric score:                   Gestational week: 
 
Type of surgery: Elective / Emergency                      ASA status: 
 
Indication: 
 
PIH History:                                              Duration: 
 
     Swelling of legs 
     Oliguria 
     Headache 
     Visual disturbances 
 
Drug history:                            dose:                            duration: 
 
Nifedepine 
Alpha methyl dopa 
MgSO4  
Aspirin 
Others 
 
Investigations: 
 
     Hb :                                 Urine albumin : 
       Blood Sugar :                                                Sugar  : 
                    Urea  :                                            deposits  : 
          Creatinine   :                                
             Uricacid  :                                 BT  :                     CT  : 
    Platelet count  :                                 PT  :                 aPTT  : 
                    LFT  : 
 
O/E  
   Anaemia  :                         Icterus  :                Edema : 
                       PR  :                                BP  : 
     Fundus Examination :  
 
Preparation : 
 
     Antiemetic prophylaxis  
         Inj. Ranitidine 50mg i.v. 
        Inj. Metoclopromide 10 mg i.v. 
I.V.Infusion of 0.9% NS – 10ml / kg 
 
Anaesthesia – SAB 
 
 Position  :  Rt lateral 
 Space   :  L3 – L4 
 Needle  :  23G 
 Drug   :  0.5% Bupivacaine Hcl 1.8ml 
 
Intra op: 
 
 Wedge 10cm ht under right hip  
 Oxytocin used  
 Sedation : Inj. Midazolam 0.05mg/kg i.v. 
 Shivering / vomiting 
 
MAP < 30% of initial value treat with ephedrine 6 mg incremental doses 
 
Parameters monitored  
 
TIME PR SBP DBP MAP SpO2 Ephedrine used 
Prior to SAB   
Imm. after 
SAB 
      
2 min       
4 min   
6 min   
8 min       
10 min   
15 min   
20 min       
25 min   
30 min   
35 min       
40 min   
45 min       
50 min       
60 min   
90 min       
120 min       
                                                                
Total ephedrine 
 
Neonatal outcome  
 APGAR score: 0min              1min                        5min 
 
Total fluids infused: 
Urine Output: 
                                                                                                     Signature 
